Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
09/2008
09/23/2008CA2480800C Inhibitors of akt activity
09/23/2008CA2432872C Pyrazole compounds useful as protein kinase inhibitors
09/23/2008CA2378382C Carboxylic acid amides, pharmaceutical compositions containing these compounds, the use and preparation thereof
09/23/2008CA2354852C 4,5-azolo-oxindoles
09/23/2008CA2210109C Method to prevent transplant rejection
09/18/2008WO2008112863A1 Compounds for the treatment of hepatitis c
09/18/2008WO2008112851A1 Cyclopropyl fused indolobenzazepine hcv inhibitors
09/18/2008WO2008112848A1 Compounds for the treatment of hepatitis c
09/18/2008WO2008112841A1 Compounds for the treatment of hepatitis c
09/18/2008WO2008112734A1 Heterocyclic-carbonyl-diazabicycloalkanes as modulators of the neuronal nicotinic acetylcholine alpha 4 beta 2, subtype receptor for the treatment of cns related disorders
09/18/2008WO2008112473A1 Compounds for the treatment of hepatitis c
09/18/2008WO2008111978A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
09/18/2008WO2008111635A1 Novel porphyrazine dye, ink, ink set, and colored material
09/18/2008WO2008111092A1 Crystalline temozolomide monohydrate and process for preparation thereof
09/18/2008WO2008110611A1 Organic compounds and their uses
09/18/2008WO2008110598A1 Tricyclic isoquinoline derivatives for treatment of obesity
09/18/2008WO2008090286A3 Derivatives of imidazo, pyrimido and diazepine pyrimidine-dione, and use thereof as a drug
09/18/2008WO2008087278A3 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy as selective ligands of v2 vasopressin receptors
09/18/2008WO2008063232B1 Substituted pyrazolopyrimidines
09/18/2008WO2008045998A3 Enantiomerically enriched iminopyrrolidone aziridine compositions
09/18/2008US20080227981 Charge transport compositions and electronic devices made with such compositions
09/18/2008US20080227980 Preparation of a 7H-Pyrrolo [2,3-D] Pyrimidine Derivative
09/18/2008US20080227973 Use of Phthalocyanines as Marking Substances for Liquids
09/18/2008US20080227961 Chelation compounds, radionuclides
09/18/2008US20080227797 Pyridopyrimidine Derivatives as Pde4 Inhibitors for the Treatment of Inflammatory and Immune Diseases
09/18/2008US20080227796 7-Amino-6-Hetaryl-1,2,4-Triazolo[1,5-A]Pyrimidine Compounds and the Use Thereof for Controlling Pathogenic Fungi
09/18/2008US20080227795 6(2-Chloro-5-Halophenyl)Triazolopyrimidines, Their Preparation And Their Use For Controlling Harmful Fungi, And Compositions Comprising These Compounds
09/18/2008US20080227788 1-Carbocyclyl- or heterocyclyl-substituted 3-substituted imidazo[1,5-a]pyrazin-8-ylamine derivatives, e.g., 1-(3-Benzyloxy-phenyl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-ylamine; inhibitor of IGF-1R enzyme; treating many diseases including cancer, respiratory diseases, ulcers, and cardiovascular diseases
09/18/2008US20080227786 Novel Crystalline Salts of a Dipeptidyl Peptidase-IV Inhibitor
09/18/2008US20080227781 Imidazole compounds for the treatment of neurodegenerative disorders
09/18/2008US20080227772 Diazabicyclic Aryl Derivatives as Nicotinic Acetylcholine Receptor Ligands
09/18/2008US20080227768 treating a bacterial infection selected from the group consisting of Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli and Pseudomonas aeruginosa
09/18/2008US20080226945 Imidazopyrimidine-based compound and organic light-emitting device employing organic layer including the same
09/18/2008US20080226674 Anticancer drugs encapsulated in and mixed with envelop protein virus vector; intensify immunology response in animals
09/18/2008US20080226593 Compounds for the Treatment of Hepatitis C
09/18/2008US20080226592 Enzyme inhibitors; interferons; interleukins; cyclosporins
09/18/2008US20080226591 Compounds for the Treatment of Hepatitis C
09/18/2008US20080226590 Compounds for the Treatment of Hepatitis C
09/18/2008DE102007012645A1 Substituierte Imidazo- und Triazolopyrimidine Substituted imidazo and triazolopyrimidines
09/18/2008CA2681162A1 Benzyl and pyridine derivatives as modulators of hedgehog pathway
09/18/2008CA2681093A1 Compounds for the treatment of hepatitis c
09/18/2008CA2680819A1 Novel porphyrazine coloring matter, ink, ink set and colored product
09/18/2008CA2679346A1 Tricyclic isoquinoline derivatives for treatment of obesity
09/18/2008CA2677713A1 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy
09/17/2008EP1970376A1 Imidazopyrimidine-based compound and organic light-emitting device employing organic layer including the same
09/17/2008EP1970373A1 Alicyclic heterocyclic compound
09/17/2008EP1968980A1 Muscarinic receptor antagonists
09/17/2008EP1968979A2 9-membered heterobicyclic compounds as inhibitors of protein kinases
09/17/2008EP1968958A1 Substituted thiazoles and their use for producing drugs
09/17/2008EP1968938A1 Substituted propiolic acid amides and their use for producing drugs
09/17/2008EP1968937A1 Deazapurine analogs of 1'-aza-l-nucleosides
09/17/2008EP1968581A2 Tetracyclic kinase inhibitors
09/17/2008EP1604991B1 Antitumor effect potentiator and antitumor agent
09/17/2008EP1272827B1 Analyte detection
09/17/2008CN101268080A A new route to formyl-porphyrins
09/17/2008CN101268079A Pyridazinone derivatives used for the treatment of pain
09/17/2008CN101268078A Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor
09/17/2008CN101268077A Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators
09/17/2008CN101268065A Process for preparing an angiotensin II receptor antagonist
09/17/2008CN101268064A Pyrazine derivatives useful as adenosine receptor antagonists
09/17/2008CN101265261A Porphyrin-fullerene assembling body and its preparation and use as functional material
09/17/2008CN101265260A Imidazopyrimidine-based compound and organic light-emitting device employing organic layer including the same
09/17/2008CN100418971C Heteroryl-fused pyrimidinyl compounds as anticancer agents
09/17/2008CN100418969C Process for preparing natural chlorophyll and products thereof with spearmint as raw material
09/17/2008CN100418968C Pirazino(aza)indole derivatives
09/17/2008CN100418967C Tricyclic inhibitors of poly(ADP-ribose) polymerases
09/17/2008CN100418955C Novel Benzo-fused heterocycles
09/17/2008CN100418951C Cycloamine derivative and its use as medicine
09/16/2008US7425631 Compounds and methods of use
09/16/2008US7425573 Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration
09/16/2008US7425562 Inhibitors of cruzipain and other cysteine proteases
09/16/2008US7425561 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
09/16/2008US7425559 Medicine containing pyrimidine derivative
09/16/2008US7425557 Inhibitors of glycogen synthase kinase 3
09/16/2008US7425554 1,2-di(cyclic)substituted benzene compounds
09/16/2008US7425318 Amyloid plaque aggregation inhibitors and diagnostic imaging agents
09/16/2008CA2515338C Inhibitors of histone deacetylase
09/12/2008WO2008109584A1 Hcv ns5b inhibitors
09/12/2008WO2008109336A1 Tetrahydroisoquinoline compounds as modulators of the histamine h3 receptor
09/12/2008WO2008107418A1 Fused pyrimidinone compounds as mglur ligands
09/12/2008WO2008107397A1 METHOD FOR THE PRODUCTION OF β-KETONITRILES
09/12/2008WO2008075955A3 Process for the preparation of 1,4,5-trisubstituted triazoles and 3,4,5-trisubstituted triazoles
09/12/2008WO2008071650A3 Novel compounds useful for the treatment of degenerative & inflammatory diseases
09/12/2008WO2008070507A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
09/12/2008WO2008063609A3 Diimide-based semiconductor materials and methods of preparing and using the same
09/12/2008WO2008057994A3 Pyrrolotriazine kinase inhibitors
09/12/2008WO2007137168A3 Bridged aryl piperazines derivatives useful for the treatment of cns, gi-urinary and reproductive disorders
09/12/2008WO2007107594A3 Six-membered heterocycle substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
09/12/2008WO2004078116A9 P38 inhibitors and methods of use thereof
09/12/2008CA2680312A1 Metalloprotease inhibitors containing a heterocyclic moiety
09/12/2008CA2679735A1 Tetrahydroisoquinoline compounds as modulators of the histamine h3 receptor
09/12/2008CA2679287A1 Method for the production of .beta.-ketonitriles
09/12/2008CA2678463A1 Fused pyrimidinone compounds as mglur ligands
09/11/2008US20080221326 Shaped Body Containing a Microporous Material and at Least One Silicon-Containing Binder, Method For the Production Thereof and Its Use as a Catalyst, Particularly in a Method For Producing Triethylenediamine (Teda)
09/11/2008US20080221322 Chemical process
09/11/2008US20080221319 Method of making porphyrins
09/11/2008US20080221196 Pharmaceutically active isoindoline derivatives
09/11/2008US20080221136 Novel Pyrrolo [3,2-D]Pyrimidin-4-One Derivatives And Their Use In Therapy
09/11/2008US20080221132 Multi-Functional Small Molecules as Anti-Proliferative Agents
09/11/2008US20080221130 2-methyl-5-methyl-6-(p-ethylphenyl)-7-aminopyrazolopyrimidine; improved activity and/or a widened activity spectrum
1 ... 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 ... 573